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Biallelic loss-of-function LACC1/
FAMIN Mutations presenting as 
Rheumatoid Factor-Negative 
polyarticular Juvenile Idiopathic 
Arthritis
Raquel Rabionet  1,2,3, Agustín Remesal4, Anna Mensa-Vilaró5,6, Sara Murías4, 
Rosa Alcobendas4, Eva González-Roca5, Estibaliz Ruiz-ortiz5,6, Jordi Antón 6, 
estibaliz Iglesias6, Consuelo Modesto7, David Comas  8, Anna puig1, Oliver Drechsel  1, 
stephan ossowski  1,10, Jordi Yagüe5, Rosa Merino4, Xavier estivill  9 & Juan I. Arostegui5
Juvenile idiopathic arthritis (JIA) is a complex rheumatic disease with both autoimmune and 
autoinflammatory components. Recently, familial cases of systemic-onset JIA have been attributed to 
mutations in LACC1/FAMIN. We describe three affected siblings from a Moroccan consanguineous family 
with an early-onset chronic, symmetric and erosive arthritis previously diagnosed as rheumatoid factor 
(RF)-negative polyarticular JIA. Autozygosity mapping identified four homozygous regions shared by 
all patients, located in chromosomes 3, 6 (n:2) and 13, containing over 330 genes. Subsequent whole 
exome sequencing identified two potential candidate variants within these regions (in FARS2 and 
LACC1/FAMIN). Genotyping of a cohort of healthy Moroccan individuals (n: 352) and bioinformatics 
analyses finally supported the frameshift c.128_129delGT mutation in the LACC1/FAMIN gene, leading 
to a truncated protein (p.Cys43Tyrfs*6), as the most probable causative gene defect. Additional 
targeted sequencing studies performed in patients with systemic-onset JIA (n:23) and RF-negative 
polyarticular JIA (n: 44) revealed no pathogenic LACC1/FAMIN mutations. Our findings support the 
homozygous genotype in the LACC1/FAMIN gene as the defect underlying the family here described 
with a recessively inherited severe inflammatory joint disease. Our evidences provide further support to 
the involvement of LACC1/FAMIN deficiency in different types of JIA in addition to the initially described 
systemic-onset JIA.
Juvenile idiopathic arthritis (JIA) refers to an arthritis of unknown origin, starting before the 16th birthday and 
lasting for at least 6 weeks1. It represents the most common pediatric rheumatic condition2. Its diagnosis relies 
on the criteria of the International League of Associations of Rheumatology, defining seven different subtypes: 
Systemic-onset JIA (SoJIA), oligoarticular, rheumatoid factor (RF)-positive polyarticular, RF-negative polyarticu-
lar, enthesitis-related, psoriatic and undifferentiated arthritis1. All JIA subtypes are genetically complex disorders 
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that lack a well-defined mode of inheritance, however, as with other complex disorders, there are a small number 
of cases following Mendelian inheritance. Genome-wide association studies (GWAS) have identified different 
loci as susceptibility factors, including the MHC and PTPN22 loci3–5. Recently, recessively inherited LACC1/
FAMIN mutations have been identified in families with monogenic forms of arthritis including SoJIA6,7, severe 
debilitating arthropathy and Crohn’s disease8, oligoarticular JIA7,9, polyarticular JIA9 and enthesitis-related JIA9.
We herein describe three siblings born from a consanguineous couple and presenting with RF-negative pol-
yarticular JIA, in which we identified a novel homozygous LACC1/FAMIN mutation as the causative defect. These 
results add novel evidences of the role of this gene in the pathogenesis of a severe form of early-onset inflamma-
tory joint disease and support the clinical diversity of this rare disease. In addition, we present the results of the 
genetic screening of LACC1/FAMIN in 67 JIA patients with different JIA subtypes, performed to assess the role of 
LACC1/FAMIN in sporadic cases of JIA.
Results
Clinical description. We describe three siblings born from a consanguineous Moroccan couple (pedigree 
in Fig. 1A) with no familial history of autoimmune disease, primary immunodeficiency, metabolic disease or 
rheumatological disease. All three siblings were afflicted by an early-onset, severe, chronic and symmetric pol-
yarthritis affecting both large and small joints. Fever was detected at disease onset in only one patient, whereas 
none of the patients presented with skin manifestations at disease onset. In patient II-4, recurrent, self-limited 
painful erysipelas-like plaques on the legs have appeared in the past two years. Laboratory analyses revealed 
leukocytosis, thrombocytosis, anemia, marked increases of inflammatory markers, and negative results for RF, 
anti-nuclear antibodies (ANAs) and HLA-B*27 (See Table 1 and Supplementary Fig. 1 for a detailed description 
of each patient). These features lead to a proposed diagnosis of RF-negative polyarticular JIA. All patients received 
both local and systemic treatments, including DMARDs, steroids, anti-TNF, anti-CD20 and anti-IL-6 drugs. All 
administered treatments were non-effective or provoked only partial responses, with the only exception of the 
anti-IL-6 tocilizumab that resulted in complete response in Patient II-4 (Table 1).
Molecular genetics. We postulated an autosomal recessive mode of inheritance for the disease based on the 
rare phenotype, its presence in individuals of both genders in the same generation, and the presence of familial 
consanguinity. To identify the underlying gene defect, a combination of genome wide SNP genotyping and WES 
was performed. SNP genotyping in three affected and one unaffected individuals revealed four different homozy-
gosity regions, located at chromosomes 3, 6 (n: 2) and 13, exclusively shared by all patients. These regions covered 
Figure 1. Panel (A). Family’s pedigree. Black filled symbols represent affected individuals, open symbols, 
unaffected individuals, squares, male individuals, and circles, female individuals. The asterisks indicate 
individuals evaluated by whole-exome sequencing. Panel (B). (top) Genomic organization of the LACC1/
FAMIN gene and (bottom) Sanger sense chromatograms from a homozygous wild-type healthy control (left 
box), heterozygous individuals (middle box), and homozygous mutated patients (right box). The asterisks 
indicate the two deleted nucleotide positions detected in the patients. Panel (C). (top) Normal structure 
of laccase protein, and (bottom) predicted structure of the truncated protein encoded by the mutated 
p.Cys43Tyrfs*6 LACC1/FAMIN allele.
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approximately 50.61 Mb and contained over 330 genes (Supplementary Table 1). No rare CNVs overlapping with 
genes were identified in the selected regions. WES was performed in two affected (II-2, II-4) and one unaffected 
(II-3) siblings. After filtering for novel or rare (minor allele frequency (MAF) <0.005) homozygous variants, 
two candidate variants within the homozygosity regions were identified: c.506A > T; p.Asp169Val in the FARS2 
gene and c.128_129delGT; p.Cys43Tyrfs*6 in the LACC1/FAMIN gene (Table 2). Sanger sequencing in all family 
members confirmed intrafamilial co-segregation of both variants with the phenotype, following a recessive mode 
of inheritance. These variants were subsequently genotyped in a control group of healthy Moroccan people. Of the 
two variants, only the FARS2 variant was present in the control group (MAF: 0.0014%). Therefore, based on the 
ACMG classification10 we classified the FARS2 variant as a variant of unknown significance (VUS), as it has not 
previously been related to disease, it is classified in ClinVar database as a VUS, it is located on an amino acid res-
idue that is not fully conserved through evolution (Supplementary Fig. 2), and the previously FARS2-associated 
phenotypes (spastic paraplegia and combined oxidative phosphorylation deficiency) are not related to arthritis. 
By contrast, the LACC1/FAMIN variant was classified as pathogenic, as it is a null variant (a frameshift 2-bp dele-
tion) that leads to a much shorter open reading frame (p.Cys43Tyrfs*6) (Fig. 1C), it is absent in public databases 
and in the group of healthy Moroccan controls, and the LACC1/FAMIN gene has been linked to various arthritis 
Patient II-2 Patient II-4 Patient II-5
Gender Female Male Female
Age (yrs) 31 19 17
Disease-onset (yrs) 2 2 3
Muskuloskeletal involvement
Type of arthritis Polyarthritis Polyarthritis Polyarthritis
Chronic Yes Yes Yes
Symmetric Yes Yes Yes
Erosive Yes Yes Yes
Affected Joints
Temporomandibulars, neck, 
shoulders, elbows, right 
MCP, hips, knees
Temporomandibulars, 
neck, right wrist, right 
MCP, PIP, DIP, knees, 
ankles, tarsal, MTP
Temporomandibulars, 
shoulders, elbows, 
wrists, MCP, PIP, 
knees, ankles
Others
Hip prosthetic replacement 
at 18 yrs, severe deformity 
in flexion at hip, primary 
lymphedema at left leg
Marked failure to thrive 
(-3SD), marked reduction 
of ankle mobility, carpitis, 
tarsitis, astragalus 
horizontalized, marked 
muscle atrophy
Fever Low-grade fever at disease-onset No Yes (at disease-onset)
Skin rash No Yes (painful erysipela-like plaque at leg) No
WBC (normal 3700–11600 cells/ml)* 12880 13200 10880
Platelets (normal 125–350 × 103 cells/ml)* 446 × 103 709 × 103 452 × 103
Haemoglobin (normal 13–17.5 g/dl)* 12.9 9.5 10.6
CRP (normal <5 mg/l)* 71 119 44
ESR (normal <20 mm/h)* 72 92 92
RF Negative Negative Negative
ANAs Negative Negative Negative
HLA-B*27 Negative Negative Negative
Synovial Fluid
Cellularity 72180 cells/ml 126000 cells/ml 19900–66700 cells/ml
PMN 70% 99% 60–94%
Treatments
Not effective Methotrexate (15 mg/m
2 
q1w)
Methotrexate (15 mg/
m2 q1w)
Etanercept (0.4 mg/kg/
twice a week)
Infliximab (3 mg/kg/ q8w)
Azathioprine (2 mg/Kg 
q1d)
Systemic and 
intraarticular steroids
Methotrexate (15 mg/
m2 q1w)
Etanercept (0.4 mg/kg/
twice a week)
Partial response
Systemic and intraarticular 
steroids
Infliximab (3 mg/kg/ q8w)
Adalimumab (40 mg q2w)
Systemic and intraarticular 
steroids
Rituximab (375 mg/m2; 
2 doses)
Tocilizumab (8 mg/
kg q2w)
Complete response Tocilizumab (8 mg/kg q2w)
Table 1. Summary of clinical and laboratory data of enrolled patients. Abbreviations: yrs, years; MCP, 
metacarpophalangeal; PIP, proximal interphalangeal; DIP, distal interphalangeal; MTP, metatarsophalangeal; 
SD, standard deviation; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor, 
ANA, anti-nuclear antibodies; PMN, polymorphonuclears. *Laboratory parameters collected at the first visit in 
the department of Pediatric Rheumatology of the Hospital La Paz.
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related phenotypes. Thus, the LACC1/FAMIN variant is the most likely causative gene defect for the disorder 
detected in this family.
LACC1/FAMIN sequencing in JIA patients. Lately, four articles have described pathogenic or likely path-
ogenic variants in the LACC1/FAMIN gene in patients with different types of JIA6–9. To investigate the potential 
role of this gene in the pathogenesis of sporadic JIA, we sequenced LACC1/FAMIN in two different groups of 
unrelated, sporadic patients of Spanish ancestry with (1) SoJIA (n: 23) and (2) RF-negative polyarticular JIA (n: 
44). The sequencing revealed two missense variants, which were not predicted to be pathogenic by functional 
prediction algorithms. Variant p.Lys38Glu was detected in heterozygosis in one soJIA case, while variant p.Ile-
254Val was present in heterozygosis in 9 SoJIA and 13 RF-negative polyarticular JIA cases and in homozygosis in 
two RF-negative polyarticular JIA cases (Table 3). This variant is also present in the Spanish general population. 
Based on data from the Geuvadis exome variant server (geevs.crg.eu) or the collaborative Spanish variant server 
(www.csvs.babelomics.org), the populational frequency of the variant is similar to that observed in our dataset 
(observed MAF in JIA cases 0.194; MAF for Spanish samples 0.2197/0.202; Table 3). This suggests that LACC1/
FAMIN mutations are not major factors to cause these JIA subtypes.
Discussion
We describe a consanguineous Moroccan family with a severe joint inflammatory disease that shows a recessive 
mode of inheritance. Genetic analyses identified the homozygous p.Cys43Tyrfs*6 LACC1/FAMIN mutation as 
the most probable causative gene defect. The LACC1/FAMIN gene, previously known as C13orf31, encodes for 
laccase domain containing 1, a member of the blue multicopper oxidases. These enzymes were first identified 
in plants and fungi, where they catalyze the oxidation of aromatic substrates concomitantly to the reduction of 
molecular oxygen to water11. Previous articles have associated LACC1/FAMIN variants with inflammatory dis-
eases, suggesting a potential relationship of human laccase with inflammatory processes12,13. Functional studies 
of wild-type and variant LACC1/FAMIN provided a mechanism for its involvement in the inflammatory response 
as a controller of energy homeostasis in macrophages and show that a reduced or complete loss of function may 
promote sterile inflammation14.
Recent reports have described LACC1/FAMIN gene variants in patients with different monogenic JIA sub-
types. The first described pathogenic variant in LACC1, p.Cys284Arg, cosegregated with disease in a consanguin-
eous family from Saudi Arabia with a complex phenotype including Crohn’s disease and a severe arthropathy8. 
Variant Gene
Refseqa nucleotide 
and Amino Acid 
change
Population Genetics Bioinformatic Analyses
1000 Genomes 
Project (n: 5008 
alleles)
ExAC (n: >120000 
alleles)
gnomAD (n: 
>246000 alleles)
Morrocan Healthy 
Group (n: 704 alleles) SIFT 
(Score)
Polyphen-2 
(Score)
Mutation 
Taster ACMGMAF Het/Hom MAF Het/Hom MAF Het/Hom MAF Het/Hom
Chr6:5369309A > T FARS2 c.506A > T p.(Asp169Val) 0.0006 3/0 0.0003 36/0 0.0004 108/0 0.0014 1/0 Del (0)
Pos Dam 
(0.883) Dis Caus VUS
Chr13 44455248 delGT LACC1/FAMIN
c.128_129delGT 
p.(Cys43Tyrfs*6) 0 0/0 0 0/0 0 0/0 0 0/0 — — Dis Caus Pathogenic
Table 2. Details of detected gene variants. aRefSeq: FARS2 gene, NM_006567.3; LACC1/FAMIN gene, 
NM_153218.2. Abbreviations: MAF, Minor Allele Frequency; ExAC, Exome Aggregation Consortium; 
gnomAD, Genome Aggregation Database; SIFT, Sorting Intolerant from Tolerant; ACMG, American College 
of Medical Genetics and Genomics classification; Het, Heterozygous; Hom, Homozygous; Del, Deleterious; Pos 
Dam, Possibly Damaging; Dis Caus, Disease Causing; VUS, Variant of Uncertain Significance.
JIA subtype Patients
Nucleotide 
changea
Amino acid 
changea Genotype SNP ID
Bioinformatic analyses
SIFT (Score)
PolyPhen-2 
(Score)
CADD 
(PHRED)
GEEVS 
MAF
CSVS 
MAF
GnomAD 
MAF
SoJIA
1–13 No changes No changes
14 c.112A > G p.Lys38Glu Het rs34414396 Tolerated (0.31) Benign (0.0) 15.13 0 0.003 0.0063
15–23 c.760A > G p.Ile254Val Het rs3764147 Tolerated (1) Benign (0.001) 16.56 0.2197 0.202 0.2748
RF-negative Pol-JIA
1–29 No changes No changes
30–31 c.760A > G p.Ile254Val Hom rs3764147 Tolerated (1) Benign (0.001) 16.56 0.2197 0.202 0.2748
32–44 c.760A > G p.Ile254Val Het rs3764147 Tolerated (1) Benign (0.001) 16.56 0.2197 0.202 0.2748
Table 3. Results of LACC1/FAMIN genotyping in patients with juvenile idiopathic arthritis (JIA). aNCBI 
Reference Sequence NM_153218.2. GnomAD MAF: global MAF from the Genome Aggregation Database; 
GEEVS MAF: MAF in the Spanish dataset of the Geuvadis European Exome data Server; CSVS MAF: MAF 
from the collaborative Spanish variant server. Abbreviations: SoJIA, systemic-onset JIA; RF, Rheumatoid Factor; 
Pol-JIA, polyarticular JIA; SIFT, Sorting Intolerant from Tolerant; CADD, Combined Annotation Dependent 
Depletion.
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This same variant was also identified in five additional consanguineous families from Saudi Arabia diagnosed 
with SoJIA6. Subsequently, different homozygous LACC1/FAMIN variants have been detected in consanguine-
ous families from various ancestries with different types of JIA7,9, including start codon mutations (p.Met1Ile), 
in-frame deletions (p.Ile330del) and truncating variants (p.Thr276fs*2, p.Arg414Ter). We have identified a novel 
frameshift truncating LACC1/FAMIN mutation in homozygosity in three JIA cases. This variant, p.Cys43Tyrfs*6, 
generates a shorter open reading frame of only 49 amino acids with a new stop codon in exon 2, which likely leads 
to nonsense mediated mRNA decay and absence of human laccase in the affected siblings.
All described families with LACC1/FAMIN mutations seem to share some clinical features such as the age 
at disease onset, the hematological and biochemical profiles, and the pattern of joint involvement, including its 
chronic course, symmetry, and number and type of affected joints. Nevertheless, marked differences in their 
phenotypes may be also observed. Thus, most of the patients of the families reported by Wakil et al., Patel et al., 
and Kallinich et al. had fever, cutaneous lesions, serositis, organomegaly or lymphadenopathy, supporting their 
diagnosis as SoJIA6–8. By contrast, most of the patients reported by Karacan et al. and the family here described 
did not present with fever or cutaneous lesions at disease onset. In these patients the joint involvement was the 
most prominent manifestation at disease onset and showed a chronic and polyarticular course, suggesting the 
diagnosis of polyarticular JIA9. Despite LACC1/FAMIN mutations have been repeatedly identified in Mendelian 
forms of JIA, we failed to detect homozygous or compound heterozygous carriers of rare pathogenic LACC1 
variants in the two groups of Spanish JIA patients analyzed, suggesting that mutations in LACC1 are not a major 
cause of JIA, and reinforcing the genetic complexity of this disorder. In fact, although common SNPs in LACC1/
FAMIN (including variant p.Ile254Val) have been associated to non-systemic JIA in a Swedish cohort15, we do 
not replicate this association in our small dataset, which has a similar carrier frequency to that of the Spanish 
population obtained from exome sequencing databases. Consequently, all available evidences strongly suggest 
that biallelic LACC1/FAMIN mutations may provoke a severe form of early-onset inflammatory arthritis, and its 
screening could only benefit those patients with very early-onset JIA.
In summary, our findings describe a novel LACC1/FAMIN mutation as the causative defect of a recessively 
inherited, severe inflammatory joint disease. The clinical features of these patients add novel evidences that the 
phenotype of this rare genetic disease includes forms of JIA other than SoJIA. The collected data support a rele-
vant role of the LACC1/FAMIN gene in inflammatory processes, indicating that further research into its function 
and its role as a therapeutic target may improve diagnosis and treatment of patients with JIA and other common 
inflammatory diseases.
Methods
patients. The patients’ data were collected by direct interviews and by the review of their clinical charts. 
Blood samples were collected for genetic and molecular studies after obtaining written-informed consent from 
patients or patients’ parents (<18 years), and approval by the ethics committee of Hospital Clinic. All protocols 
were approved by the Ethics Committee of Hospital Clinic and all methods were performed in accordance with 
the relevant guidelines and regulations. The control groups included a group of healthy Moroccan individuals (n: 
352), and two groups of sporadic Spanish patients with either SoJIA (n: 23) or RF-negative polyarticular JIA (n: 
44), which were diagnosed according the criteria of the International League of Associations of Rheumatology. 
Genetic studies were performed in accordance with the Declaration of Helsinki.
Homozygosity mapping. DNA was isolated from whole blood using QIAmp DNA Blood Mini Kit 
(QIAgen, Germany). SNPs were genotyped with HumanCNV370-Duo Beadchip (Illumina Inc, USA), and ana-
lyzed for homozygosity mapping using AutoSNPa16. Copy number variants (CNVs) detection from SNP geno-
typing was performed using PennCNV17.
Whole-exome sequencing (Wes). Libraries were prepared with the SureSelect Human All exon V2 kit 
(Agilent Technologies Inc, USA). Paired-end sequencing was performed on the Illumina Genome Analyzer II 
platform (Illumina Inc, USA). The sequence reads were aligned to the Human Reference Genome Build hg19 
using the BWA software18, followed by GATK base quality score recalibration, duplicate marking and local rea-
lignment. SNPs and indels were simultaneously called in all samples using the GATK HaplotypeCaller algorithm, 
applying hard-filtering parameters according to GATK best practices recommendations19. Variants were anno-
tated and prioritized using ediva, our in-house pipeline (www.ediva.crg.eu), which provides information on minor 
allele frequencies from various databases, including the Exome Aggregation Consortium, and Exome Variant 
Server-NHBLI, variant functional effect prediction scores by SIFT, Polyphen2, MutationAssessor and CADD, and 
variant conservation scores PhyloP and Gerp++. Fastq files can be accessed through EGA (EGAS00001003510).
LACC1/FAMIN sanger sequencing. Coding exons of LACC1/FAMIN were amplified by PCR, purified 
with Illustra ExoStar 1-Step kit (GE Healthcare, USA), fluorescence sequenced using ABI BigDye® Terminator 
v3.1 Cycle Sequencing Kit (Applied Biosystems, USA) and run on an automated ABI 3730XL DNA analyzer.
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